Bluejay Investor Presentation Deck

Symphony™M IL-6 Test: Rapid Results in Critical Care Settings Quantitative determination of IL-6 by fluorescence enzyme immunoassay from whole blood specimens ●●● bluejay DIAGNOSTICS Interleukin-6 (IL-6) is an Early Responder Biomarker During Trauma or Infection. Important in: Sepsis And Covid-19 Related Sepsis Acute Respiratory Distress Syndrome Measuring IL-6 could help medical professionals make earlier and actionable treatment decisions. Rapid turnaround time crucial as IL-6 specimens become more unstable over time Multi-organ Failure Rheumatoid Arthritis Autoimmune Disorders Cardiovascular Diseases Copyright ©2022 Bluejay Diagnostics, Inc. All rights reserved in all slides | October 2022 5

View entire presentation